IQVIA MedTech’s Post

How are GLP-1s impacting your business? If you’re not clear, it’s time to cut through the noise with IQVIA MedTech, as our experts uncover the challenges and opportunities of GLP-1s – allowing you to plan with confidence for a successful MedTech future. Watch on-demand: https://bit.ly/3U7Vt0f #GLP #MedTech

How are GLP-1s impacting your business? If you’re not clear, it’s time to cut through the noise with IQVIA MedTech, as our experts uncover the challenges and opportunities of GLP-1s – allowing you to plan with confidence for a successful MedTech future. Watch on-demand: https://bit.ly/3zPPplX #GLP1 #MedTech

The European Union's new #HTA Regulation introduces the Joint Clinical Assessment (#JCA), a harmonized approach to clinical evaluations that will reshape the way biotech and medtech companies navigate the Market Authorization Application (MAA) process.    We are excited to invite you to our upcoming webinar on a key development that will transform Marketing in Europe: "How to Master both Marketing Authorization and Joint Clinical Assessment Successfully". 🗓 Date & Time: Oct. 17th, 13:00 CET 📢 Format: Online session 👉 Free registration: https://lnkd.in/ePKqFAZN Decebal Bora, Gabrielle Nayroles, Christelle Fasano, Susan Benjamin, Saku Torvinen, PhD, Linsen Du #Regulatory #MarketAccess

Book your seat! Last chance to register to this free webinar to learn how the Joint Clinical Assessment (JCA) will impact your Marketing Authorization Application (MAA) in Europe.

FDA inspections are nobody’s idea of a good time. However, proper planning can go a long way to not only ensuring baseline compliance, but also to establishing an effective corporate culture and building long-term company value. In this edition of Consultants Corner, we spotlight advice from Jamie Harris, MPH, RAC and Nancy Lince, RAC, who discussed the issue onstage last month at the MedTech Strategist Innovation Summit in Dublin: https://bit.ly/44EOS1y #medicaldevices #medtech #fda #InnovationDublin24

Unlock the potential of GLP-1 treatments through insights extracted from unstructured conversational data. Our blog explores how these insights are shaping understanding of patient and healthcare professional perspectives. Learn more about the revolutionary impact of GLP-1 drugs in modern healthcare by clicking the link below. https://hubs.la/Q02JHTgz0

📢📅 We're excited to announce an upcoming webinar by Voisin Consulting Life Sciences (VCLS) titled "How to Successfully Master Both Market Authorization and Joint Clinical Assessment." Don't miss out—register now and gain valuable insights! #MedEngine #TheValueIsInTheLinks #VCLS #MarketAccess

Key discussions today at the Swiss Medtech National Regulatory Conference 2024 in Bern! We’re tackling how European regulations are impacting innovation and the shift towards a trust-based system. Regulatory bodies need to work more closely with manufacturers, who are the real experts on their products, to streamline the process without compromising safety and trust. This isn’t just about regulators, it’s about the patients, too. We need to ensure that patients trust that the innovations reaching the market are safe, effective, and developed with their needs in mind. As Daniel Delfosse and Phil Brown pointed out, these challenges are shared across Europe, making collaboration between manufacturers, regulators, and patients essential for moving forward. #MedTech #Compliance #Regulatory #FDA #Healthcare

In our last webinar on “Developing an Effective Regulatory Strategy for the Evolving 2024 Medtech Landscape” we asked attendees: “What’s the most important factor in building a regulatory strategy?” Although all the answers were correct, the poll underscores a critical trend – MedTech companies increasingly need to master unique regulatory requirements across markets. The #Regulatory #MedTech Department of Alira Health can support you in this regulatory challenge to bring a product to market successfully. If you missed our webinar, you can watch it now to help guide your MedTech regulatory strategy: https://lnkd.in/g3KD3BRX

🔍 Million dollar question: where should you launch a new medical device or combination product first, in the EU or in the US? What are the current challenges in both areas? 🤔 If you wondered abou that, come meet us at the Swiss National Regulatory Conference, and let's discuss the best approach together. confinis will be engaging with peers and industry experts on the key regulatory challenges facing Europe today as part of Swiss Medtech. 🌍🩺 We’re excited to share insights and help you navigate these complex times. #innovators #regulatory #compliance #andbeyond #SwissRegulatoryConference #MedTech #RegulatoryStrategy #EUvsFDA